News

On Thursday, shares in Charles River Laboratories, a leading contract research organizations that has stirred controversy ...
The FDA is moving away from requiring animal models for investigational new drug (IND) applications for new monoclonal ...
The U.S. Food and Drug Administration said on Thursday it plans to replace animal testing in the development of monoclonal ...
The initiative, which will start with monoclonal antibodies, is the first big regulatory shift from the FDA since Martin ...
The Food and Drug Administration (FDA) announced Thursday it plans to phase out animal testing requirements for biological ...
Recuresion Pharma (RXRX) stock and other AI-driven biotechs surge as FDA embraces computational models over animal testing ...
Recursion Pharmaceuticals' stock is soaring today on news the FDA is planning on phasing out some animal testing, replacing ...
The US Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies ...
Analysts at William Blair expect drug developers will continue to perform “at least some animal testing” on their investigational products. Though the process to phase out animal testing will begin ...
The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...
improves neuron health in animal models of Alzheimer's disease, according to a new study. Experimental drug NU-9 -- a small molecule compound approved by the U.S. Food and Drug Administration (FDA ...
The Food and Drug Administration on Thursday said it would begin phasing out animal testing requirements for antibody ...